We are live on ! Find out more
GC

Globeflex Capital Portfolio holdings

AUM $783M
1-Year Est. Return 81.58%
This Fund
S&P 500
This Quarter Est. Return
+34.81%
1 Year Est. Return
+81.58%
3 Year Est. Return
+185.88%
5 Year Est. Return
+280.02%
10 Year Est. Return
+1,365.88%
AUM
$783M
AUM Growth
+$122M
Cap. Flow
-$22.1M
Cap. Flow %
-2.82%
Top 10 Hldgs %
18.08%
Holding
456
New
69
Increased
67
Reduced
73
Closed
62

Top Buys

Rank Stock Value
1
CIEN icon
Ciena
CIEN
+$6.96M
2
MYRG icon
MYR Group
MYRG
+$4.57M
3
DRS icon
Leonardo DRS
DRS
+$4.16M
4
SMTC icon
Semtech
SMTC
+$3.99M
5
P
Everpure Inc
P
+$3.43M

Top Sells

Rank Stock Value
1
CPRX
Catalyst Pharmaceutical
CPRX
+$11.2M
2
BAP icon
Credicorp
BAP
+$9.17M
3
NXT icon
Nextpower Inc. Common Stock
NXT
+$6.93M
4
XP icon
XP
XP
+$6.54M
5
STRL icon
Sterling Infrastructure
STRL
+$5.21M

Sector Composition

Rank Sector Weight
1 Technology 27.29%
2 Industrials 19.78%
3 Financials 17.73%
4 Healthcare 17.14%
5 Consumer Discretionary 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TGT icon
326
Target
TGT
$72.6B
$173K 0.02%
+1,322
New +$168K
RNR icon
327
RenaissanceRe
RNR
$13.7B
$171K 0.02%
539
– –
PCTY icon
328
Paylocity
PCTY
$7.76B
$170K 0.02%
1,624
– –
LHX icon
329
L3Harris
LHX
$46.7B
$162K 0.02%
557
– –
STRW icon
330
Strawberry Fields REIT
STRW
$196M
$161K 0.02%
11,731
– –
HR icon
331
Healthcare Realty
HR
$6.31B
$161K 0.02%
7,988
– –
RGA icon
332
Reinsurance Group of America
RGA
$16B
$161K 0.02%
+757
New +$158K
CFR icon
333
Cullen/Frost Bankers
CFR
$9.92B
$159K 0.02%
1,032
– –
BSVN icon
334
Bank7 Corp
BSVN
$521M
$159K 0.02%
3,244
– –
MKTX icon
335
MarketAxess Holdings
MKTX
$5.75B
$156K 0.02%
1,371
– –
BY icon
336
Byline Bancorp
BY
$1.7B
$154K 0.02%
4,095
– –
HII icon
337
Huntington Ingalls Industries
HII
$10.9B
$152K 0.02%
544
– –
SYY icon
338
Sysco
SYY
$37.9B
$152K 0.02%
1,817
– –
ROST icon
339
Ross Stores
ROST
$73.3B
$151K 0.02%
711
– –
MAGN
340
Magnera Corp
MAGN
$416M
$147K 0.02%
+12,524
New +$137K
PEGA icon
341
Pegasystems
PEGA
$5.93B
$147K 0.02%
4,900
– –
BCO icon
342
Brink's
BCO
$4.39B
$146K 0.02%
1,541
– –
CCBG icon
343
Capital City Bank Group
CCBG
$860M
$144K 0.02%
2,915
– –
STLN
344
Starling Oncology
STLN
$676M
$142K 0.02%
+26,111
New +$110K
V icon
345
Visa
V
$691B
$141K 0.02%
410
– –
MTSI icon
346
MACOM Technology Solutions
MTSI
$20.1B
$136K 0.02%
+357
New +$118K
TEL icon
347
TE Connectivity
TEL
$59.8B
$136K 0.02%
673
– –
TSN icon
348
Tyson Foods
TSN
$18.4B
$134K 0.02%
+2,338
New +$146K
EGAN icon
349
eGain
EGAN
$142M
$133K 0.02%
21,093
– –
THRM icon
350
Gentherm
THRM
$1.16B
$133K 0.02%
+3,885
New +$125K
12 13
14
15 16

Similar funds

CC
Converium Capital Montreal $783M AUM
CCG
Chatham Capital Group Savannah, Georgia $783M AUM 31.99% 1-Year Est. Return
LF
Longbow Finance Lutry, Switzerland $782M AUM 48.76% 1-Year Est. Return
LF
Lee Financial Dallas, Texas $783M AUM 23.98% 1-Year Est. Return
TWM
Topsail Wealth Management Charlotte, North Carolina $783M AUM 19.25% 1-Year Est. Return
SFWA
Summit Financial Wealth Advisors Lafayette, Louisiana $782M AUM 24.35% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
CWP
CFM Wealth Partners Austin, Texas $783M AUM 47.07% 1-Year Est. Return

Globeflex Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Globeflex Capital held 456 positions worth $783M, up 18% from $661M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Globeflex Capital's Q2 2026 filing shows 69 new, 67 increased, 73 reduced and 62 closed positions. Its largest new stake was Ciena: 13,648 shares worth $6.7M. The largest sale was Catalyst Pharmaceutical, an estimated $11.2M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Industrials and Financials.

  • Globeflex Capital's largest Q2 2026 buy was Ciena: 13,648 shares worth $6.7M.
  • Globeflex Capital added most to MYR Group in Q2 2026, an estimated $4.57M increase.
  • Globeflex Capital's biggest Q2 2026 reduction was Rigel Pharmaceuticals, cutting an estimated $3.24M.
  • Globeflex Capital fully exited Catalyst Pharmaceutical in Q2 2026, selling an estimated $11.2M.
  • Globeflex Capital's ten largest holdings make up 18% of its $783M portfolio in Q2 2026.
  • Globeflex Capital opened 69 new positions and closed 62 in Q2 2026.
  • Globeflex Capital's portfolio value rose 18% quarter-over-quarter to $783M.

Based on Globeflex Capital's 13F filing for Q2 2026, filed 12 Aug 2026.